Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Oncology

Symptoms & Diagnosis: Getting the Right Answer

At a Glance

Anaplastic Large Cell Lymphoma (ALCL) is a rare cancer that requires an excisional biopsy for accurate diagnosis. Symptoms vary by type but can include swollen lymph nodes, persistent fevers, night sweats, skin nodules, or fluid around a breast implant. CD30 protein testing confirms the disease.

Getting a clear answer for Anaplastic Large Cell Lymphoma (ALCL) is often a journey of ruling out more common conditions. Because ALCL is rare and can “mimic” other illnesses, it requires a high level of suspicion and very specific diagnostic tests to identify correctly [1][2].

Recognizing the Signs

The symptoms of ALCL depend on which “type” is present. While some signs are obvious, others are easily overlooked or mistaken for minor issues.

Systemic ALCL (ALK+ and ALK-)

This type affects the whole body and often presents with what doctors call B-symptoms [3]:

  • Persistent Fevers: Fevers that come and go, often without a clear cause like a cold or flu [4].
  • Drenching Night Sweats: Sweats so intense they require changing pajamas or sheets [4].
  • Unexplained Weight Loss: Losing weight without trying [4].
  • Painless Swelling: Lumps in the neck, armpit, or groin that do not hurt [5].

Primary Cutaneous ALCL (pcALCL)

This version starts in the skin. It typically looks like red nodules or tumors that may form an open sore (ulcerate) [6][7]. Because they can look like a stubborn skin infection or a bug bite, they are sometimes misdiagnosed for weeks or months.

Breast Implant-Associated ALCL (BIA-ALCL)

The most common symptom is late seroma—a sudden swelling caused by fluid buildup around a breast implant, usually occurring years after the surgery [8][9]. It can also appear as a lump or mass near the implant [10].

Avoiding Diagnostic Pitfalls

Because ALCL is rare, it is frequently mistaken for other conditions initially. Knowing these “mimics” can help you advocate for a deeper look.

  • The “Stubborn Cyst”: ALCL can look like a ruptured epidermal cyst or an abscess [1]. If a “cyst” does not heal with antibiotics or standard wound care, it must be biopsied [1][11].
  • The “Reactive” Node: Sometimes an enlarged lymph node is dismissed as a reaction to a minor infection. If the swelling persists, more investigation is needed [12].
  • Sarcoidosis or Infection: On imaging like a PET scan, ALCL can look very similar to inflammatory diseases like sarcoidosis or even tuberculosis [13].

The “Gold Standard” Diagnosis

The most critical step in getting the right answer is the biopsy—taking a piece of the tissue to look at under a microscope.

Why Excisional Biopsy Matters

There are different ways to take a biopsy, but they are not all equal for lymphoma:

  1. Excisional Biopsy (The Gold Standard): The surgeon removes the entire lymph node or the whole mass [14][15]. This allows the pathologist to see the “architecture” of the tissue, which is vital for a correct diagnosis [16][5].
  2. Fine Needle Aspiration (FNA): A thin needle removes a few cells. While quick, FNA often doesn’t provide enough tissue to distinguish ALCL from other cancers [17][18].
  3. Core Needle Biopsy (CNB): A larger needle takes a “core” of tissue. It is better than FNA but still carries a risk of missing the cancer or providing an incomplete picture [18][12].

Specialized Testing

Once the tissue is collected, the laboratory performs flow cytometry (a way of laser-scanning cells) and immunohistochemistry (using special stains or antibodies to color specific proteins on the tissue) to find the CD30 marker [19][20]. They also check for the ALK protein [21]. Distinguishing ALK-negative ALCL from other T-cell lymphomas (like PTCL-NOS) is critical because the treatments and expected outcomes can be very different [22][23]. This distinction often requires advanced molecular tests like DUSP22 or TP63 rearrangements [24][22].

Return to Home

Common questions in this guide

What are the main symptoms of systemic ALCL?
Systemic ALCL often causes 'B-symptoms', which include persistent fevers, drenching night sweats, and unexplained weight loss. Patients may also notice painless swelling in their lymph nodes, particularly in the neck, armpit, or groin.
Why is an excisional biopsy recommended for diagnosing ALCL?
An excisional biopsy involves removing an entire lymph node or mass, which allows the pathologist to see the tissue's complete structure. This provides the best chance for an accurate diagnosis, whereas a needle biopsy might not collect enough cells to confirm ALCL.
What does CD30 and ALK testing mean for ALCL?
Pathologists use specialized lab tests on biopsy tissue to look for specific proteins like CD30 and ALK. The presence of the CD30 marker helps confirm an ALCL diagnosis, while ALK testing determines the specific subtype of the lymphoma, which guides treatment decisions.
How does breast implant-associated ALCL (BIA-ALCL) usually appear?
The most common symptom of BIA-ALCL is a sudden buildup of fluid around a breast implant, known as a late seroma. This swelling typically occurs years after the initial implant surgery and should be evaluated by a doctor.
Can ALCL skin lesions be mistaken for something else?
Yes, primary cutaneous ALCL appears as red nodules or tumors on the skin that can sometimes ulcerate. Because they look similar to stubborn bug bites, cysts, or skin infections, they are frequently misdiagnosed until a proper biopsy is performed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was an excisional biopsy performed, and did it provide enough tissue for a definitive diagnosis?
  2. 2.Did the pathology report mention 'hallmark cells' or specific T-cell markers like CD3, CD5, and CD30?
  3. 3.For my (or my child's) case, how was ALK-negative ALCL distinguished from other T-cell lymphomas like PTCL-NOS?
  4. 4.Were molecular tests like DUSP22 or TP63 rearrangements performed on the biopsy sample?
  5. 5.In the case of breast implants, was the fluid tested specifically with flow cytometry for CD30?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Anaplastic lymphoma kinase-negative primary systemic anaplastic large cell lymphoma mimicking a ruptured epidermal cyst of the scalp: a case report and literature review.

    Ahn IY, Bae TH, Kang SH, et al.

    Archives of craniofacial surgery 2024; (25(6)):298-302 doi:10.7181/acfs.2024.00262.

    PMID: 39551572
  2. 2

    Breast implant-associated anaplastic large cell lymphoma: a review.

    Quesada AE, Medeiros LJ, Clemens MW, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019; (32(2)):166-188 doi:10.1038/s41379-018-0134-3.

    PMID: 30206414
  3. 3

    Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

    Blombery P, Thompson ER, Jones K, et al.

    Haematologica 2016; (101(9)):e387-90 doi:10.3324/haematol.2016.146118.

    PMID: 27198716
  4. 4

    Recurrent Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma Presenting as a Breast Implant-Associated Lesion.

    Zimmerman A, Locke FL, Emole J, et al.

    Cancer control : journal of the Moffitt Cancer Center 2015; (22(3)):369-73 doi:10.1177/107327481502200317.

    PMID: 26351895
  5. 5

    Rosai-Dorfman disease mimicking IgG4-related disease.

    Cetin O, Yetisir S, Akpinar TS, et al.

    Wiener medizinische Wochenschrift (1946) 2026; (176(1-2)):60-63 doi:10.1007/s10354-025-01110-x.

    PMID: 40924281
  6. 6

    No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course.

    Schrader AM, Chung YY, Jansen PM, et al.

    Blood 2016; (128(1)):141-3 doi:10.1182/blood-2016-02-694455.

    PMID: 27146432
  7. 7

    Primary Cutaneous Anaplastic Large Cell Lymphoma with Locoregional Lymph Node Involvement: Challenges in Diagnosis and Clinical Management.

    Garcia-Garcia M, Tardin Cardoso AL, Val IS, et al.

    The American Journal of dermatopathology 2025; (47(11)):866-870 doi:10.1097/DAD.0000000000003103.

    PMID: 40810669
  8. 8

    Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma.

    Alcalá R, Llombart B, Lavernia J, et al.

    Journal of cutaneous pathology 2016; (43(7)):602-608 doi:10.1111/cup.12697.

    PMID: 26956670
  9. 9

    Our Experience in Diagnosing and Treating Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

    Shoham G, Haran O, Singolda R, et al.

    Journal of clinical medicine 2024; (13(2)) doi:10.3390/jcm13020366.

    PMID: 38256500
  10. 10

    Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer center.

    Dashevsky BZ, Gallagher KM, Grabenstetter A, et al.

    The breast journal 2019; (25(1)):69-74 doi:10.1111/tbj.13161.

    PMID: 30521149
  11. 11

    Anaplastic Lymphoma Kinase (ALK)-Positive Anaplastic Large Cell Lymphoma Presenting as an Axillary Breast Abscess in a Young Woman: A Case Report.

    Amamnkwah D, Ibrahim F

    Cureus 2025; (17(12)):e99911 doi:10.7759/cureus.99911.

    PMID: 41445989
  12. 12

    Ultrasound-guided core needle biopsies for workup of lymphadenopathy and lymphoma.

    Groneck L, Quaas A, Hallek M, et al.

    European journal of haematology 2016; (97(4)):379-86 doi:10.1111/ejh.12742.

    PMID: 26833691
  13. 13

    18 F-FDG PET/CT in Synovial Anaplastic Large Cell Lymphoma.

    Chiu KL, Chow TK, Ma WH, Ma KM

    Clinical nuclear medicine 2024; (49(7)):666-668 doi:10.1097/RLU.0000000000005140.

    PMID: 38409753
  14. 14

    Comparative analysis on efficacy of lymph node sampling through whole node excision versus core needle biopsy: focusing on diagnostic yield for interpretation.

    Singh N, Mishra S, Balasubramanian P, et al.

    Journal of hematopathology 2025; (18(1)):46 doi:10.1007/s12308-025-00662-6.

    PMID: 41087604
  15. 15

    Evaluation of peripheral lymphadenopathy with excisional biopsy: six-year experience.

    Özkan EA, Göret CC, Özdemir ZT, et al.

    International journal of clinical and experimental pathology 2015; (8(11)):15234-9.

    PMID: 26823872
  16. 16

    Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience.

    Campanelli M, Cabry F, Marasca R, Gelmini R

    Minerva chirurgica 2019; (74(3)):218-223 doi:10.23736/S0026-4733.18.07752-0.

    PMID: 30306770
  17. 17

    Fine Needle Aspirate Flow Cytometry's Ancillary Utility in Diagnosing Non-Hodgkin Lymphoma in the Head and Neck.

    Bandargal S, Florianova L, Dmitrienko S, et al.

    Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 2024; (53()):19160216241296127 doi:10.1177/19160216241296127.

    PMID: 39511788
  18. 18

    Can Cutting-Needle Biopsy Be an Alternative to Excisional Biopsy in Lymph Node Pathologies?

    Kiliçarslan A, Doğan M, Süngü N, et al.

    Turk patoloji dergisi 2017; (1(1)):235-239 doi:10.5146/tjpath.2016.01393.

    PMID: 28832072
  19. 19

    [Expression of microRNA in ALK-negative anaplastic large cell lymphoma and CD30-positive peripheral T cell lymphoma, not otherwise specified].

    Wang C, Chen X, Chen X, et al.

    Zhonghua bing li xue za zhi = Chinese journal of pathology 2015; (44(8)):565-70.

    PMID: 26705180
  20. 20

    Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.

    De Azambuja AP, Gevert F, Oliveira RM, et al.

    Cytometry. Part B, Clinical cytometry 2022; (102(4)):312-316 doi:10.1002/cyto.b.22040.

    PMID: 34791787
  21. 21

    Differential diagnosis and identification of prognostic markers for peripheral T-cell lymphoma subtypes based on flow cytometry immunophenotype profiles.

    Pu Q, Qiao J, Liu Y, et al.

    Frontiers in immunology 2022; (13()):1008695 doi:10.3389/fimmu.2022.1008695.

    PMID: 36466894
  22. 22

    Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.

    de Pádua Covas Lage LA, Brito CV, Levy D, et al.

    Leukemia research 2022; (114()):106794 doi:10.1016/j.leukres.2022.106794.

    PMID: 35131666
  23. 23

    Fine-Needle Aspiration Biopsy Diagnosis of T-Cell Non-Hodgkin Lymphomas: Morphologic Features, Ancillary Testing, and Diagnostic Pitfalls.

    Cozzolino I, Zeppa P, Medeiros LJ

    Acta cytologica 2026; 1-22 doi:10.1159/000550789.

    PMID: 41628100
  24. 24

    ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.

    Parkhi M, Bal A, Das A, et al.

    Applied immunohistochemistry & molecular morphology : AIMM 2021; (29(9)):648-656 doi:10.1097/PAI.0000000000000936.

    PMID: 33901030

This page explains ALCL symptoms and diagnostic tests for educational purposes only. Always consult your oncologist or healthcare team for medical advice and accurate diagnosis interpretation.

Get notified when new evidence is published on Anaplastic large cell lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.